Literature DB >> 17682035

Sentinel node biopsy confers no added protection to patients with melanoma.

Spyros Retsas1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17682035      PMCID： PMC1939951          DOI： 10.1177/014107680710000820

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  16 in total

1.  Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients.

Authors:  S Retsas; K Henry; M Q Mohammed; K MacRae
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

Review 2.  Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part II.

Authors:  Neil S Medalie; A Bernard Ackerman
Journal:  Am J Dermatopathol       Date:  2003-12       Impact factor: 1.533

3.  Cutaneous melanoma.

Authors:  Spyros Retsas
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

4.  Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.

Authors:  Joseph Meirion Thomas
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

5.  The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.

Authors:  Timothy M Pawlik; Merrick I Ross; John F Thompson; Alexander M M Eggermont; Jeffrey E Gershenwald
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544

Review 6.  Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.

Authors:  Shailendra Verma; Ian Quirt; David McCready; Kate Bak; Manya Charette; Neill Iscoe
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

Review 7.  Cutaneous melanoma.

Authors:  John F Thompson; Richard A Scolyer; Richard F Kefford
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

Review 8.  Adjuvant therapy of melanoma.

Authors:  Lynn E Spitler
Journal:  Oncology (Williston Park)       Date:  2002-01       Impact factor: 2.990

9.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

10.  Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.

Authors:  John C Kang; Leslie A Wanek; Richard Essner; Mark B Faries; Leland J Foshag; Donald L Morton
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.